Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

30.71
+0.90003.02%
Post-market: 30.780.0700+0.23%17:58 EDT
Volume:2.41M
Turnover:73.81M
Market Cap:4.88B
PE:-10.12
High:31.82
Open:31.78
Low:29.85
Close:29.81
Loading ...

Q1 2025 Ionis Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
1 hour ago

Ionis Pharmaceuticals’ Earnings Call Highlights Growth Amid Challenges

TIPRANKS
·
7 hours ago

Ionis Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
12 hours ago

Ionis Pharmaceuticals: Strong Financial Performance and Strategic Partnerships Justify Buy Rating Despite Adjusted Price Target

TIPRANKS
·
12 hours ago

Ionis Pharmaceuticals: Strong Performance and Promising Pipeline Justify Buy Rating

TIPRANKS
·
12 hours ago

Ionis Pharmaceuticals Narrows Q1 Loss, Lifts Revenue Forecast While Drug Sales Surge

Benzinga
·
13 hours ago

BUZZ-Ionis Pharma rises after lifting 2025 revenue forecast

Reuters
·
Yesterday

Ionis Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Yesterday

Stock Track | Ionis Pharmaceuticals Soars 6.88% Pre-Market on Strong Q1 Results and Raised 2025 Guidance

Stock Track
·
Yesterday

Ionis Pharmaceuticals (IONS) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks
·
Yesterday

Ionis Pharmaceuticals Q1 Net Loss Narrows as Revenue Increases; 2025 Revenue Guidance Raised

MT Newswires Live
·
Yesterday

Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
Yesterday

Ionis Pharmaceuticals: Q1 Earnings Snapshot

Associated Press Finance
·
Yesterday

Earnings Flash (IONS) Ionis Pharmaceuticals Posts Q1 EPS Loss $0.93, vs. FactSet Est of $1.10 Loss

MT Newswires Live
·
Yesterday

Ionis Pharmaceuticals Q1 Adj. EPS $(0.93) Beats $(1.12) Estimate, Sales $132.00M Beat $125.32M Estimate

Benzinga
·
Yesterday

BRIEF-Ionis Pharmaceuticals Q1 Revenue USD 132 Million Vs. IBES Estimate USD 125.3 Million

Reuters
·
Yesterday

Ionis Pharmaceuticals Inc: Increasing 2025 Financial Guidance by More Than 20%

THOMSON REUTERS
·
Yesterday

Ionis Pharmaceuticals Inc Outlook 2025 REV $725 Mln -$750 Mln

THOMSON REUTERS
·
Yesterday

Ionis Pharmaceuticals: on Track for Second Independent Launch With Donidalorsen Pdufa August 21, 2025

THOMSON REUTERS
·
Yesterday

Ionis reports first quarter 2025 financial results

Business Wire
·
Yesterday